However, if it is true that upregulation of ACE2 activity by the virus contributes to COVID-19 pathogenesis, targeting only the canonical ACE-AT2-AT2R1 axis might not be enough and that could explain the mild results obtained so far. This evidence concerns the gene AGTR1 and COVID-19.